CDT Equity Registers 16.8M Shares for Resale, Including Sarborg Acquisition Shares and J.J. Astor Note Conversion Shares
CDT is trading near its 52-week low of $0.157 (8.6% above the low) on elevated volume (9.7× avg).
Summary
CDT Equity registered 16.8M shares for resale by selling stockholders, including 12.1M shares issued for the Sarborg AI acquisition and shares underlying the $2.1M J.J. Astor convertible note. The company receives no proceeds; existing shareholders face significant potential dilution.
Key Events · Financing and Capital Events · CDT
-
16.8M Shares Registered for Resale
The prospectus supplement registers 16,825,644 shares for resale by selling stockholders, including 12,131,122 shares issued to Sarborg Limited shareholders for the AI company acquisition and 650,000 additional Sarborg shares under Amendment No. 1.
-
J.J. Astor Note Conversion Shares Registered
The registration covers 3,523,125 conversion shares and 365,750 warrant shares underlying the $2.1M senior secured convertible note issued to J.J. Astor & Co. on September 14, 2026, with a VWAP-based conversion price floored at $0.05.
-
Service Provider Shares Registered
Shares issued to five service providers are also registered: 32,110 to EX-ANIMO, 25,000 to Maxim Partners, 31,373 to Ian Burton, 33,582 to NJS Foresight, and 33,582 to Thesprogen.
-
No Proceeds to Company
The company will not receive any proceeds from the resale of these shares by selling stockholders; all proceeds go to the selling stockholders.
Analysis · CDT · Life Sciences
This prospectus supplement registers 16,825,644 shares for resale by selling stockholders, including 12.1M shares issued to Sarborg Limited shareholders for the AI company acquisition, 3.5M conversion shares and 365,750 warrant shares underlying the $2.1M J.J. Astor convertible note, and shares issued to five service providers. The registration makes these shares immediately tradable, creating significant potential selling pressure on a stock with a market cap of only ~$2.4M. The company receives no proceeds from these resales. This follows a pattern of deeply dilutive survival financing: the Q2 10-Q showed only $747K in cash, a going concern warning, and the company has now issued multiple convertible notes to J.J. Astor with VWAP-based conversion prices floored at $0.05. The registration of 12.1M Sarborg shares is particularly notable — it exceeds the company's current outstanding share count and represents the equity consideration for the AI acquisition.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 36.8% of the 990 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CDT was trading at $0.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.16 to $1,778.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.